Blockchain in Telecom Market Size, Growth, Scope and Forecast 2022-2027

According to IMARC Group’s latest report, titled “Blockchain in Telecom Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027.’ The global blockchain in telecom market reached a value of US$ 275 Million in 2021. A blockchain refers to a growing list of records, also called blocks, that are linked together utilizing cryptography. Every block comprises of a cryptographic hash of the previous block, a timestamp, and transaction data. Blockchain is a decentralized technological solution used for collecting, recording, and maintaining the transaction history of digital assets between two or more parties. It is utilized by organizations to streamline administrative procedures, prevent thefts, store unique device data, create transparent networks, curb fraudulent activities, etc. Blockchain also aids in enhancing the operational efficiency of the business processes and assists in tracking the historical records of the users, which can be verified by other stakeholders. Blockchain in telecom is used widely for smart contracts, identity management, connectivity provisioning, payment, billing, etc.



We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report

Request for a PDF sample of this report:  https://www.imarcgroup.com/blockchain-in-telecom-market/requestsample

The escalating data security concerns among telecom organizations are some of the key factors driving the blockchain in telecom market. Besides this, the incorporation of the Internet of Things (IoT) and artificial intelligence (AI) with connected devices is further catalyzing the market growth. Moreover, the widespread adoption of blockchain technology in the telecom industry to reduce identity and roaming frauds is acting as another growth-inducing factor. In line with this, the increasing demand for smart contracts to manage all of the billing related to roaming to ensure significant cost savings is also stimulating the market growth. Additionally, the integration of 5G technology and the elevating utilization of blockchain-based mobile wallet payments are anticipated to fuel the blockchain in telecom market over the forecasted period. Looking forward, IMARC Group expects the market to reach US$ 4,969 Million by 2027, exhibiting at a CAGR of 62.46% during 2022-2027.

Competitive Landscape:

·         Amazon.com Inc.

·         Blockchain Foundry Inc.

·         Cegeka

·         Deloitte Touche Tohmatsu Limited

·         Huawei Technologies Co.Ltd.

·         Infosys Limited

·         International Business Machines Corporation

·         Microsoft Corporation

·         Oracle Corporation

·         SAP SE

·         Tbcasoft Inc.

·         Wipro Limited.

Key Market Segmentation:

Breakup by Provider:

·      Application Providers

·      Middleware Providers

·      Infrastructure Providers 

Breakup by Organization Size:

·      Small and Medium-sized Enterprises

·      Large Enterprises 

Breakup by Application:

·      OSS/BSS Processes

·      Identity Management

·      Payments

·      Smart Contracts

·      Connectivity Provisioning

·      Others

Breakup by Region:

•        North America (United States, Canada)

•        Europe (Germany, France, United Kingdom, Italy, Spain, Others)

•        Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)

•        Latin America (Brazil, Mexico, Others)

•        Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures:  https://bit.ly/3ONxwXK

We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:                                                           

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Value Chain Analysis
  • Structure of the Global Market
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us        

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

 

 

Comments

Post a Comment

Popular posts from this blog

Outsourcing in Banking: Enhancing Efficiency and Addressing Risks

Image
Outsourcing in the banking sector has become a crucial strategy for streamlining products and services, optimizing resource management, reducing costs, and ultimately delivering greater value to customers. As financial institutions navigate a complex regulatory landscape, they are increasingly focusing on their core activities and looking for ways to enhance operational efficiency. The Need for Cost Optimization Banks face various challenges, including capital requirements, financial reporting, and corporate governance standards. Many institutions have shifted their attention from global capital markets to concentrate on their fundamental banking operations. This shift is essential not only for compliance but also for maintaining competitiveness in a market where operating costs significantly impact the pricing of financial products. To remain competitive, banks must find ways to lower their operational costs without compromising service quality. This is where outsourcing comes into pl...
Read more

North America Frozen Seafood Market: Industry Overview, Growth, Trends, Opportunities and Forecast Till 2026

Image
 According to IMARC Group’s latest report, titled “ North America Frozen Seafood Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 ”, the North America frozen seafood market reached a value of US$ 13.4 Billion in 2020. Frozen seafood products are preserved for inhibiting the growth of bacteria in order to increase their shelf life, taste, and nutritional value. The seafood freezing technique includes two different approaches, namely, cryofreezing and carboxymethylcellulose. In cryofreezing, seafood items, such as salmon, tuna, shrimp, oysters, and tilapia, are kept in ultra-low liquid nitrogen for maintaining their quality. On the other hand, carboxymethylcellulose is used to curb the adulteration of seafood commodities. We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. Request for a PDF sample of this report : https...
Read more

Biosimilar Market Size 2022-27: Trends, Share, Growth, Opportunity and Forecast

Image
According to the recent report by IMARC Group, entitled “ Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 ”, the  global biosimilar market size was estimated to be US$ 13.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 60.8 Billion by 2027, exhibiting at a CAGR of 26.1% during 2022-2027. Biosimilars, also known as subsequent entry biologics (SEBs) or follow-on biologics, refer to FDA-approved biotherapeutic products which are similar to their reference biologics. Biosimilars can only be manufactured after the patent of the reference product expires. The demand for biosimilars has been increasing in recent years as they help in reducing the overall cost of the treatment for a variety of chronic diseases including cancers, autoimmune diseases, kidney failure, diabetes, CVDs, haematological disorders, infectious diseases, rheumatoid arthritis, growth hormone deficiency, etc. We are regularly track...
Read more